Table 1 Relation between XB130 expression and clinicopathologic variables in pancreatic cancer patients
From: Prognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinoma
XB130 expression | ||||
|---|---|---|---|---|
Variables | Number | High (n) | Low (n) | P value |
Gender | ns | |||
Male | 48 | 31 | 17 | |
Female | 28 | 12 | 16 | |
Age (years) | ns | |||
<60 | 45 | 29 | 16 | |
≥60 | 31 | 14 | 17 | |
TNM stage | 0.001 | |||
I | 12 | 3 | 9 | |
II | 39 | 18 | 21 | |
III | 19 | 16 | 3 | |
IV | 6 | 6 | 0 | |
Tumour size | ns | |||
≤2 cm | 50 | 32 | 18 | |
>2 cm | 26 | 11 | 15 | |
T classification | 0.013 | |||
T1/T2 | 15 | 4 | 11 | |
T3/T4 | 61 | 39 | 22 | |
N classification | 0.017 | |||
N0 | 25 | 8 | 17 | |
N1 | 51 | 35 | 16 | |
Histologic differentiation | ns | |||
Well (G1) | 30 | 18 | 12 | |
Moderate (G2) | 28 | 15 | 13 | |
Poor (G3) | 18 | 10 | 8 | |
Distant metastasis | 0.0024 | |||
M0 | 60 | 29 | 31 | |
M1 | 16 | 14 | 2 | |
Lymphatic invasion | ns | |||
Yes | 14 | 8 | 6 | |
No | 59 | 35 | 24 | |
Vascular invasion | ns | |||
Yes | 18 | 10 | 8 | |
No | 58 | 33 | 25 | |
Perineural invasion | ns | |||
Yes | 8 | 3 | 5 | |
No | 68 | 40 | 28 | |
Chemotherapy | ns | |||
No | 32 | 20 | 12 | |
Yes | 44 | 23 | 21 | |